Ryuta Uraki

4.4k total citations · 1 hit paper
56 papers, 1.3k citations indexed

About

Ryuta Uraki is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Ryuta Uraki has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 25 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Ryuta Uraki's work include SARS-CoV-2 and COVID-19 Research (22 papers), Influenza Virus Research Studies (19 papers) and Respiratory viral infections research (16 papers). Ryuta Uraki is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (22 papers), Influenza Virus Research Studies (19 papers) and Respiratory viral infections research (16 papers). Ryuta Uraki collaborates with scholars based in United States, Japan and Uganda. Ryuta Uraki's co-authors include Yoshihiro Kawaoka, Erol Fikrig, Seiya Yamayoshi, Jesse Hwang, Andrew K. Hastings, Maki Kiso, Akiko Iwasaki, Kellie A. Jurado, Mutsumi Ito and Sarah Householder and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Ryuta Uraki

54 papers receiving 1.3k citations

Hit Papers

A human isolate of bovine H5N1 is transmissible and letha... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuta Uraki United States 22 717 570 463 266 207 56 1.3k
Brett W. Jagger United States 23 736 1.0× 1.4k 2.4× 478 1.0× 593 2.2× 490 2.4× 32 2.0k
Ricardo Khouri Brazil 21 550 0.8× 463 0.8× 942 2.0× 248 0.9× 261 1.3× 97 1.6k
Jillian M. Carr Australia 23 731 1.0× 262 0.5× 729 1.6× 413 1.6× 442 2.1× 72 1.7k
Peeraya Ekchariyawat Thailand 13 809 1.1× 518 0.9× 936 2.0× 280 1.1× 180 0.9× 26 1.4k
José Luiz Proença‐Módena Brazil 23 570 0.8× 352 0.6× 337 0.7× 278 1.0× 191 0.9× 75 1.3k
Kellie A. Jurado United States 17 927 1.3× 289 0.5× 467 1.0× 265 1.0× 439 2.1× 38 1.4k
Ophélie Dejarnac France 6 1.0k 1.4× 415 0.7× 1.2k 2.7× 235 0.9× 172 0.8× 7 1.6k
Fok‐Moon Lum Singapore 22 1.3k 1.8× 451 0.8× 1.3k 2.8× 331 1.2× 337 1.6× 35 2.0k
Nicholas J. Lennemann United States 16 813 1.1× 508 0.9× 526 1.1× 257 1.0× 259 1.3× 25 1.4k
Huailiang Ma China 5 319 0.4× 313 0.5× 297 0.6× 128 0.5× 87 0.4× 6 647

Countries citing papers authored by Ryuta Uraki

Since Specialization
Citations

This map shows the geographic impact of Ryuta Uraki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuta Uraki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuta Uraki more than expected).

Fields of papers citing papers by Ryuta Uraki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuta Uraki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuta Uraki. The network helps show where Ryuta Uraki may publish in the future.

Co-authorship network of co-authors of Ryuta Uraki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuta Uraki. A scholar is included among the top collaborators of Ryuta Uraki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuta Uraki. Ryuta Uraki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uraki, Ryuta, Mutsumi Ito, Maki Kiso, et al.. (2025). An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters. PubMed. 3(1). 7–7.
2.
Uraki, Ryuta, Maki Kiso, Mutsumi Ito, et al.. (2025). An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant. EBioMedicine. 117. 105794–105794. 1 indexed citations
3.
Furusawa, Yuri, Maki Kiso, Ryuta Uraki, et al.. (2025). Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures. Journal of Virology. 99(3). e0221724–e0221724.
4.
Uraki, Ryuta, Masaki Imai, Mutsumi Ito, et al.. (2024). An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants. npj Vaccines. 9(1). 4–4. 7 indexed citations
5.
Chiba, S., Maki Kiso, S. Yamada, et al.. (2024). An mRNA vaccine candidate encoding H5HA clade 2.3.4.4b protects mice from clade 2.3.2.1a virus infection. npj Vaccines. 9(1). 189–189. 6 indexed citations
6.
Halfmann, Peter, Kiyoko Iwatsuki‐Horimoto, Makoto Kuroda, et al.. (2024). Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters. Communications Biology. 7(1). 331–331. 6 indexed citations
7.
Kiso, Maki, Seiya Yamayoshi, Shun Iida, et al.. (2023). In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir. Nature Communications. 14(1). 4231–4231. 38 indexed citations
8.
Kiso, Maki, Yuri Furusawa, Ryuta Uraki, et al.. (2023). In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir. Nature Communications. 14(1). 3952–3952. 22 indexed citations
9.
Kiso, Maki, Ryuta Uraki, Mutsumi Ito, et al.. (2023). Oral intake of heat-killed Lactiplantibacillus pentosus ONRICb0240 partially protects mice against SARS-CoV-2 infection. SHILAP Revista de lepidopterología. 3. 2 indexed citations
10.
Kingstad-Bakke, Brock, Boyd L. Yount, Ryuta Uraki, et al.. (2023). Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine. JCI Insight. 8(22). 12 indexed citations
11.
Ishizaka, Aya, Michiko Koga, Taketoshi Mizutani, et al.. (2023). Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination. Virology Journal. 20(1). 146–146. 9 indexed citations
12.
Imai, Masaki, James B. Wing, Hiroaki Shime, et al.. (2022). Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer. Cancer Science. 114(4). 1256–1269. 18 indexed citations
13.
Uraki, Ryuta, Masaki Imai, Mutsumi Ito, et al.. (2021). Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens. PLoS Pathogens. 17(12). e1010085–e1010085. 15 indexed citations
14.
Shime, Hiroaki, Makoto Tsuiji, Masaki Imai, et al.. (2020). Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function. Proceedings of the National Academy of Sciences. 117(34). 20696–20705. 50 indexed citations
15.
Wu, Nicholas C., Seiya Yamayoshi, Mutsumi Ito, et al.. (2018). Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene. Cell Host & Microbe. 24(4). 569–578.e4. 33 indexed citations
16.
Uraki, Ryuta, Andrew K. Hastings, Andrea Gloria‐Soria, Jeffrey R. Powell, & Erol Fikrig. (2018). Altered vector competence in an experimental mosquito-mouse transmission model of Zika infection. PLoS neglected tropical diseases. 12(3). e0006350–e0006350. 11 indexed citations
17.
Yasuhara, Atsuhiro, Seiya Yamayoshi, Chiharu Kawakami, et al.. (2017). Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies. Scientific Reports. 7(1). 17735–17735. 20 indexed citations
18.
Jurado, Kellie A., Michael K. Simoni, Zhonghua Tang, et al.. (2016). Zika virus productively infects primary human placenta-specific macrophages. JCI Insight. 1(13). 133 indexed citations
19.
Uraki, Ryuta, Subash C. Das, Masato Hatta, et al.. (2014). Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine. Vaccine. 32(41). 5295–5300. 12 indexed citations
20.
Kiso, Maki, Ryo Takano, Saori Sakabe, et al.. (2013). Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus. Scientific Reports. 3(1). 1563–1563. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026